BIO-B vs TEM

The Advanced Deterministic Scorecard reveals a weak financial health profile with a Piotroski F-Score of just 2/9, indicating significant deterioration in fundamental performance. Despite a strong balance sheet (Current Ratio: 5.44, Debt/Equity: 0.21), the company is unprofitable (Profit Margin: -26.43%, ROE: -9.50%) and lacks meaningful valuation metrics due to negative earnings. While quarterly earnings have beaten estimates 3 out of 4 times recently, revenue growth is nearly flat (0.50% YoY), and long-term price performance remains deeply negative (-47.0% over 5 years). The absence of Altman Z-Score and Graham Number prevents a full value assessment, but current fundamentals do not support a bullish stance.

Tempus AI exhibits critical financial fragility, highlighted by a Piotroski F-Score of 1/9, indicating severe weakness across profitability and operational efficiency. While the company demonstrates explosive revenue growth of 83% YoY, this is offset by deep negative margins and a high Debt/Equity ratio of 2.70. The bearish outlook is further reinforced by aggressive insider selling, including significant divestments by the CEO and CFO, and a technical trend score of 0/100. Despite analyst optimism, the fundamental health metrics suggest a high-risk profile.